B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• describe the clinical features <strong>of</strong> Still’s disease and other febrile<br />
syndromes<br />
• describe the immunogenetic mechanisms and treatment for<br />
adult Still’s disease and related syndromes<br />
5:00 PM<br />
Training in Pediatric <strong>Rheumatology</strong>: A Proposal for Latin<br />
America<br />
Carlos D. Rose, MD; duPont Hospital for Children; Wilmington,<br />
DE<br />
tuesday<br />
B304<br />
Systemic Lupus Erythematosus: Lupus Nephritis (058)<br />
Speaker: Frederic A. Houssiau, MD, PhD; Universite Catholique<br />
Louvain; Brussels, Belgium<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• identify lupus nephritis in early stages<br />
• describe poor prognostic factors<br />
• evaluate lupus nephritis therapy<br />
B305<br />
Systemic Lupus Erythematosus: Novel Treatments<br />
(059) PS<br />
Speaker: Robert G. Lahita, MD, PhD; Newark Beth Israel Hospital;<br />
Newark, NJ<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• determine the <strong>of</strong>f-label use <strong>of</strong> commercially available agents<br />
for features <strong>of</strong> systemic lupus erythematosus<br />
• discuss investigational therapies for systemic lupus<br />
erythematosus<br />
• identify potential risks <strong>of</strong> new therapies for systemic lupus<br />
erythematosus<br />
• identify host factors which may influence response to new<br />
therapies<br />
B306<br />
Vasculitis: An Update (060) f<br />
Speaker: Stuart M. Levine, MD; Johns Hopkins University;<br />
Baltimore, MD<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• understand the strengths and limitations <strong>of</strong> the current blood<br />
vessel size-based vasculitis classification system<br />
• utilize various imaging and laboratory tests in the diagnosis<br />
<strong>of</strong> vasculitis, with emphasis on antineutrophilic cytoplasmic<br />
antibodies<br />
• identify standard and novel therapeutic modalities in the<br />
treatment <strong>of</strong> the systemic vasculitides<br />
ACR Special Session<br />
4:30 - 6:00 PM<br />
A412<br />
ILAR Global Health Project P/C<br />
Moderators: Luis R. Espinoza, MD; Louisianna State University<br />
Medical Center; New Orleans, LA<br />
Antonio C. Ximenes, PhD; Hospital Geral Goiânia; Goiania, Brazil<br />
4:30 PM<br />
ILAR: Past, Present and Future<br />
David A. Fox, MD; University <strong>of</strong> Michigan Medical Center; Ann<br />
Arbor, MI<br />
Mark Andrejeski; <strong>American</strong> <strong>College</strong> <strong>of</strong> <strong>Rheumatology</strong>; Atlanta,<br />
GA<br />
5:30 PM<br />
ILAR-East Africa <strong>Rheumatology</strong> Initiative<br />
Fotios Koumpouras, MD; Univeristy <strong>of</strong> Pittsburgh Medical<br />
Center; Pittsburgh, PA<br />
Omondi G. Oyoo, MD, MMed; University <strong>of</strong> Nairobi; Nairobi,<br />
Kenya<br />
Session Overview:<br />
The International League <strong>of</strong> Associations for <strong>Rheumatology</strong> has<br />
incurred a significant reorganization on its function, role, goals<br />
and mission in the past few years. Its member’s base (ACR,<br />
EULAR, PANLAR, APLAR); however, lacks a basic knowledge<br />
and understanding <strong>of</strong> these changes. ILAR, in order to fulfill<br />
its objectives need full support <strong>of</strong> its base and this session will<br />
assist a great deal to accomplish them.<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• describe the rationale for the reorganization<br />
• discuss the changes made<br />
• gain a better understanding <strong>of</strong> ILARS’s mission and goals<br />
• learn <strong>of</strong> funding opportunities for clinical research and<br />
education<br />
ACR REF Special Session<br />
4:30 - 6:00 PM<br />
B402<br />
REF Marshall J. Schiff, MD, Memorial Lectureship:<br />
Everything a Rheumatologist Should Know About<br />
Spine Surgery but Was Afraid to Ask c/r<br />
Moderator: Stephen A. Paget, MD; Hospital for Special Surgery;<br />
New York, NY<br />
Speaker: Scott D. Boden, MD; Emory Orthopaedics &<br />
Spine Center; Atlanta, GA<br />
Session Overview:<br />
Back pain represents one <strong>of</strong> the leading causes <strong>of</strong> loss <strong>of</strong> work<br />
days in the US, and is a common complaint in the outpatient<br />
setting. Rheumatologists need to be familiar with the latest<br />
evidence regarding diagnosis, prognosis, and indications for<br />
surgical intervention. This session will review current and<br />
emerging practices regarding spine surgery.<br />
Upon completion <strong>of</strong> this session, participants should be able to:<br />
• distinguish the different etiologies <strong>of</strong> back pain, and their<br />
common presentations<br />
• identify the indications for surgical intervention<br />
• describe the role <strong>of</strong> recent findings concerning bone<br />
morphogenetic proteins in spine fusion<br />
5:30 PM<br />
1458. Effectiveness <strong>of</strong> the Global Posture Reeducation Method<br />
(GPR) and Segmental Stretching in the Treatment <strong>of</strong> Chronic<br />
Back Pain: A Randomized Controlled Trial.<br />
Marilene M. dos Santos 3 , Larissa S. Guimarães 5 , Lorena O.<br />
Souza 5 , Mariana M. Vasconcelos 5 , Taís M. Camargo 1 , Priscylla C.<br />
84<br />
2010 Program Book